Drug safety evaluation of alemtuzumab for multiple sclerosis. (2014)

First Author: Willis M
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1517/14740338.2014.928691

PubMed Identifier: 24935240

Publication URI: http://europepmc.org/abstract/MED/24935240

Type: Journal Article/Review

Volume: 13

Parent Publication: Expert opinion on drug safety

Issue: 8

ISSN: 1474-0338